Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Serologicals Plans Midwest Plant
Serologicals Corp. of Atlanta will decide the location of a second Ex-Cyte manufacturing facility by November 30. Several locations in the Midwest are being considered as the site of the $28-million plant. Completion is slated for the first half of 2004, with a 15 to 18 month construction period.
Serologicals provides biological products and technologies for the research, development, and manufacture of biologically-based life science products.
UC San Francisco Completes Genentech Hall
The University of California at San Francisco will complete the $22-million Genentech Hall next month. The hall is the first facility of the planned 20-building, 43-acre Mission Bay campus encompassing 2,650,000 sf of instructional, support, and biomedical lab facilities. Part of Catellus Development Corp.'s massive 303-acre project, the facility is ready for support staff occupancy as early as October and will see equipment moved in through the end of the year.
Scott & White Build Round Rock Diagnostic & Specialty Care Center
Scott & White, a Temple, Texas-based healthcare company, is planning the 77,000-sf Scott & White Center for Diagnostic and Specialty Care in Round Rock. The $27-million center will house 31 physicians specializing in gastroenterology, cardiology, orthopedics, ophthalmology, and general surgery. Construction is slated to begin in June of 2003 and reach completion in late 2004.
UTSA Establishes Vaccine Research Training Facility
The University of Texas at San Antonio has leased 8,000 sf in Brooks Building 175 at Brooks Air Force Base to house a vaccine research training facility. Preparing molecular biologists, fermentation technicians, and genetic engineers to conduct vaccine-related research, the facility is slated to open by fall of 2003. The training center will accommodate both UTSA and military graduate and undergraduate students. City officials hope that the training facility will cause San Antonio to be chosen as the site of a proposed $1.5-billion national vaccine center.
UCB Pharma Expands in Smyrna
UCB Pharma, a developer and commercializer of allergy/asthma medications and central nervous system disorder treatments, will occupy a new 110,000-sf, $15-million facility in early 2003. UCB Pharma currently employs 450 workers.